查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572073

人工肺市场：按产品类型、技术、患者年龄层、组件、应用和最终用户 - 2025-2030 年全球预测

Artificial Lung Market by Product Type (Extracorporeal Membrane Oxygenation, Intrapulmonary Gas Exchange, Paracorporeal Artificial Lungs), Technology, Patient Age Group, Component, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年人工肺市场价值为70.2亿美元，预计到2024年将达到76.3亿美元，复合年增长率为8.76%，到2030年将达到126.5亿美元。

氧合器市场包括复製或支援活体肺部气体交换能力的设备和技术，主要用于管理呼吸衰竭和疾病。随着慢性呼吸道疾病在全球的流行，对氧合器系统的需求变得越来越重要。应用范围从加护病房的临时呼吸支持到肺可用性有限的移植情况下的替代。汽车、医学研究和医疗保健产业作为最终用途领域，材料和生物相容性技术的进步也越来越引起生物技术公司的兴趣。慢性阻塞性肺病（COPD）和急性呼吸窘迫症候群（ARDS）发生率的上升以及全球人口老化是市场驱动因素。随着携带式和植入式氧合器的发展，生物材料的创新可以延长设备的使用寿命，从而提供了利润丰厚的机会。然而，高製造成本、严格的监管要求和潜在的生物相容性问题等挑战可能会阻碍市场成长。为了利用商机，公司应透过奈米技术和生物相容性聚合物的研究，重点在于提高设备的效率和人体工学。探索将机械支撑和生物组织工程结合的混合系统也具有潜力。市场的本质是竞争性的，创新的时机已经成熟，主要参与者投资于研发以克服挑战和监管障碍。作为分析师，我建议投资与医学研究机构的合作，并探索官民合作关係，以促进创新并提高监管合规性。向监管宽鬆的新兴市场扩张可以放宽准入门槛并提高市场渗透率。日益开拓以患者为中心的方法（例如开发个人化氧合器解决方案）也有可能加速采用、改善患者治疗结果并推动市场扩张。

主要市场统计
基准年[2023] 70.2亿美元
预测年份 [2024] 76.3亿美元
预测年份 [2030] 126.5亿美元
复合年增长率（%） 8.76%

市场动态：揭示快速发展的人工肺市场的关键市场洞察

供需的动态交互作用正在改变制氧机市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 呼吸系统疾病和肺移植的增加推动了对人工肺的需求
    • 充氧器设计和功能的技术进步推动产业成长
    • 增加充氧器系统研发的投资和经费
    • 老年人口的增加和慢性肺部疾病发生率的增加将推动市场需求
  • 市场限制因素
    • 操作和维护充氧器设备所需的熟练专业人员和专业知识有限；
    • 对充氧器材料的生物相容性和长期耐用性的担忧会影响采用率
  • 市场机会
    • 开发人工智慧驱动的氧合器以优化呼吸支援系统
    • 再生医学方法创造长寿且耐用的人工肺
    • 制氧机与物联网集成，实现即时监控与维护
  • 市场挑战
    • 技术限制和可靠性问题阻碍了氧合器在医疗机构中的广泛使用
    • 影响人工肺部研究、开发和部署的伦理考量和社会认知问题

波特五力：驾驭制氧机市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对氧合器市场的影响

外部宏观环境因素对人工肺市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解制氧机市场的竞争状况

对人工肺市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵氧合器市场供应商绩效评估

FPNV定位矩阵是评估制氧机市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了人工肺市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，人工肺市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 呼吸系统疾病和肺移植的增加增加了对人工肺的需求
      • 充氧器设计和功能的技术进步推动产业成长
      • 增加充氧器系统研发的投资和经费
      • 老年人口的增长和慢性肺部疾病发病率的上升正在推动市场需求。
    • 抑制因素
      • 操作和维护氧合器设备所需的熟练专业人员和专业知识有限
      • 对充氧器材料的生物相容性和长期耐用性的担忧会影响采用率
    • 机会
      • 开发人工智慧驱动的人工肺以优化呼吸支援系统
      • 再生医学方法创造持久耐用的人工肺
      • 制氧机与物联网 (IoT) 集成，实现即时监控和维护
    • 任务
      • 技术限制和可靠性问题减缓了医疗机构中氧合器的使用
      • 影响人工肺部研究、开发和实施的伦理考量和舆论问题
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章人工肺市场：依产品类型

  • 体外膜氧合（ECMO）
  • 肺内气体交换
  • 体外氧合器

第七章人工肺市场：依技术分类

  • 储氧技术
  • 泵浦技术
  • 感测器和监视器

第八章依患者年龄层分類的人工肺市场

  • 成人用
  • 老年病
  • 新生
  • 小儿科

第九章人工肺市场：依组成部分

  • 插管
  • 控制器
  • 膜式充氧器
  • 泵浦

第10章人工肺市场：依应用分类

  • 急性呼吸窘迫症候群（ARDS）
  • 心肺体外迴圈
  • 慢性阻塞性肺病（COPD）

第十一章人工肺市场：依最终用户分类

  • 门诊手术中心
  • 诊所
  • 医院

第十二章美洲人工肺市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太人工肺市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东和非洲人工肺市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0598

The Artificial Lung Market was valued at USD 7.02 billion in 2023, expected to reach USD 7.63 billion in 2024, and is projected to grow at a CAGR of 8.76%, to USD 12.65 billion by 2030.

The artificial lung market encompasses devices and technologies that replicate or support the gas exchange functions of biological lungs, primarily to manage respiratory failures or diseases. With a growing prevalence of chronic respiratory diseases worldwide, the demand for artificial lung systems is becoming increasingly vital. Applications span from temporary respiratory support in intensive care units to alternatives in transplant scenarios, where lung availability is limited. Automotive, medical research, and healthcare sectors serve as end-use domains, with an increasing interest from biotechnology firms due to advancements in materials and biocompatible technologies. A significant growth driver is the rise in chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS) cases, as well as the global aging population, which boosts market potential. Innovations in biomaterials leading to improved device lifespan, alongside the development of portable and implantable artificial lungs, offer lucrative opportunities. However, challenges like high manufacturing costs, stringent regulatory requirements, and potential biocompatibility issues may impede market growth. To capitalize on opportunities, companies should focus on enhancing device efficiency and ergonomics through research into nanotechnology and biocompatible polymers. There is also potential in exploring hybrid systems that combine mechanical support with biological tissue engineering. The nature of the market is both competitive and ripe for innovation, dominated by key players investing in R&D to outpace challenges and regulatory hurdles. As an analyst, I recommend investing in collaborations with medical research institutions and exploring public-private partnerships to foster innovation and facilitate regulatory compliance. Expanding into emerging markets, which may have less stringent regulations, could offer easier entry points and further market penetration. Enhanced focus on patient-centric approaches, such as developing personalized artificial lung solutions, could also bolster adoption and improve patient outcomes, driving market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 7.02 billion
Estimated Year [2024] USD 7.63 billion
Forecast Year [2030] USD 12.65 billion
CAGR (%) 8.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Lung Market

The Artificial Lung Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of respiratory diseases and lung transplantation driving demand for artificial lungs
    • Technological advancements in artificial lung design and functionality driving industry growth
    • Growing investment and funding in research and development of artificial lung systems
    • Rising geriatric population coupled with higher incidences of chronic lung conditions enhancing market demand
  • Market Restraints
    • Limited availability of skilled professionals and expertise needed for the operation and maintenance of artificial lung devices
    • Concerns regarding biocompatibility and long-term durability of artificial lung materials affecting adoption rates
  • Market Opportunities
    • Development of ai-driven artificial lungs to optimize respiratory support systems
    • Regenerative medicine approaches for creating long-lasting and durable artificial lungs
    • Integration of internet of things (iot) with artificial lungs for real-time monitoring and maintenance
  • Market Challenges
    • Technological limitations and reliability concerns stalling the widespread acceptance of artificial lungs in healthcare settings
    • Ethical considerations and public perception issues influencing the R&D and deployment of artificial lungs

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Lung Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Lung Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Lung Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Lung Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Lung Market

A detailed market share analysis in the Artificial Lung Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Lung Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Lung Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Lung Market

A strategic analysis of the Artificial Lung Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Lung Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ALung Technologies, Inc., B. Braun Melsungen AG, Baxter International Inc., Breethe, Inc., CardiacAssist, Inc., Cleveland Clinic, Dragerwerk AG & Co. KGaA, Fresenius Medical Care AG & Co. KGaA, Getinge AB, Hemovent GmbH, Maquet Holding B.V. & Co. KG, McGowan Institute for Regenerative Medicine, Medtronic plc, Novalung GmbH, Organ Care System (OCS), Respiratory Assist, Terumo Corporation, Xenios AG, and Xenios USA, Inc.

Market Segmentation & Coverage

This research report categorizes the Artificial Lung Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Extracorporeal Membrane Oxygenation (ECMO), Intrapulmonary Gas Exchange, and Paracorporeal Artificial Lungs.
  • Based on Technology, market is studied across Oxygenator Technology, Pump Technology, and Sensors and Monitors.
  • Based on Patient Age Group, market is studied across Adult, Geriatric, Neonates, and Pediatric.
  • Based on Component, market is studied across Cannulas, Controllers, Membrane Oxygenators, and Pumps.
  • Based on Application, market is studied across Acute Respiratory Distress Syndrome (ARDS), Cardiopulmonary Bypass, and Chronic Obstructive Pulmonary Disease (COPD).
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of respiratory diseases and lung transplantation driving demand for artificial lungs
      • 5.1.1.2. Technological advancements in artificial lung design and functionality driving industry growth
      • 5.1.1.3. Growing investment and funding in research and development of artificial lung systems
      • 5.1.1.4. Rising geriatric population coupled with higher incidences of chronic lung conditions enhancing market demand
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals and expertise needed for the operation and maintenance of artificial lung devices
      • 5.1.2.2. Concerns regarding biocompatibility and long-term durability of artificial lung materials affecting adoption rates
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of ai-driven artificial lungs to optimize respiratory support systems
      • 5.1.3.2. Regenerative medicine approaches for creating long-lasting and durable artificial lungs
      • 5.1.3.3. Integration of internet of things (iot) with artificial lungs for real-time monitoring and maintenance
    • 5.1.4. Challenges
      • 5.1.4.1. Technological limitations and reliability concerns stalling the widespread acceptance of artificial lungs in healthcare settings
      • 5.1.4.2. Ethical considerations and public perception issues influencing the R&D and deployment of artificial lungs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Lung Market, by Product Type

  • 6.1. Introduction
  • 6.2. Extracorporeal Membrane Oxygenation (ECMO)
  • 6.3. Intrapulmonary Gas Exchange
  • 6.4. Paracorporeal Artificial Lungs

7. Artificial Lung Market, by Technology

  • 7.1. Introduction
  • 7.2. Oxygenator Technology
  • 7.3. Pump Technology
  • 7.4. Sensors and Monitors

8. Artificial Lung Market, by Patient Age Group

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Geriatric
  • 8.4. Neonates
  • 8.5. Pediatric

9. Artificial Lung Market, by Component

  • 9.1. Introduction
  • 9.2. Cannulas
  • 9.3. Controllers
  • 9.4. Membrane Oxygenators
  • 9.5. Pumps

10. Artificial Lung Market, by Application

  • 10.1. Introduction
  • 10.2. Acute Respiratory Distress Syndrome (ARDS)
  • 10.3. Cardiopulmonary Bypass
  • 10.4. Chronic Obstructive Pulmonary Disease (COPD)

11. Artificial Lung Market, by End-User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Clinics
  • 11.4. Hospitals

12. Americas Artificial Lung Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Artificial Lung Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Artificial Lung Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ALung Technologies, Inc.
  • 3. B. Braun Melsungen AG
  • 4. Baxter International Inc.
  • 5. Breethe, Inc.
  • 6. CardiacAssist, Inc.
  • 7. Cleveland Clinic
  • 8. Dragerwerk AG & Co. KGaA
  • 9. Fresenius Medical Care AG & Co. KGaA
  • 10. Getinge AB
  • 11. Hemovent GmbH
  • 12. Maquet Holding B.V. & Co. KG
  • 13. McGowan Institute for Regenerative Medicine
  • 14. Medtronic plc
  • 15. Novalung GmbH
  • 16. Organ Care System (OCS)
  • 17. Respiratory Assist
  • 18. Terumo Corporation
  • 19. Xenios AG
  • 20. Xenios USA, Inc

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL LUNG MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL LUNG MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL LUNG MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. ARTIFICIAL LUNG MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. ARTIFICIAL LUNG MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL LUNG MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL LUNG MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL LUNG MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY INTRAPULMONARY GAS EXCHANGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PARACORPOREAL ARTIFICIAL LUNGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY OXYGENATOR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PUMP TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY SENSORS AND MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY NEONATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CANNULAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CONTROLLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. ARTIFICIAL LUNG MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. ARTIFICIAL LUNG MARKET, FPNV POSITIONING MATRIX, 2023